Home » Topics » BioWorld Science

BioWorld Science
RSS

Two new combination substudies evaluate pembrolizumab for NSCLC

Jan. 17, 2020

Long-term safety and efficacy of AAV5-hFVIII-SQ gene therapy

Jan. 17, 2020

Evidence of activity seen in phase I trial of RMC-4630 in KRAS-mutant non-small cell lung cancer

Jan. 17, 2020

Oncogenic FHL2-GLI2 fusion identified in sclerosing stromal tumors of the ovary

Jan. 17, 2020

CADM1v8/9 variant useful to detect SCLC

Jan. 17, 2020

ViiV Healthcare UK patents HIV integrase inhibitors

Jan. 17, 2020

Adenosine A2A receptor antagonists identified at Zhejiang Vimgreen Pharma

Jan. 17, 2020

Roche, ETHZ disclose new cannabinoid CB2 receptor ligands

Jan. 17, 2020

New liver X receptor alpha and beta inverse agonists discovered at Phenex-FXR

Jan. 17, 2020

Medshine Discovery identifies isocitrate dehydrogenase mutant inhibitors

Jan. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...